Therefore, the impaired NF-κB activation is closely associated with various disorders, such as cancers, inflammatory, autoimmune, and neurodegenerative diseases, and metabolic syndrome [33,130]. This evidence concerns the gene NFKB1 and neurodegenerative disease.